Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allergan plc stock logo
AGN
Allergan
$193.02
$190.89
$114.27
$202.21
$63.50B1.24.01 million shs12.44 million shs
CVS Health Co. stock logo
CVS
CVS Health
$68.59
-0.5%
$65.96
$43.56
$71.45
$86.48B0.5711.77 million shs6.90 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$153.95
+0.2%
$159.40
$140.68
$169.99
$371.00B0.497.95 million shs7.99 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$62.88
-2.5%
$76.55
$59.32
$148.15
$282.18B0.615.85 million shs6.30 million shs
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
$13.42
-1.3%
$15.57
$12.47
$22.80
$15.22B0.729.89 million shs7.21 million shs
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$10.80
-0.5%
$10.80
$8.08
$18.83
$9.34B0.6720.98 million shs9.36 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allergan plc stock logo
AGN
Allergan
0.00%0.00%0.00%0.00%0.00%
CVS Health Co. stock logo
CVS
CVS Health
-0.30%-2.57%+2.91%+31.89%-0.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.19%+3.31%-5.52%+4.18%+6.58%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-2.45%-3.50%-21.65%-24.47%-49.06%
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
-1.21%-5.26%-19.81%-38.09%+2.44%
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-0.46%+0.19%-4.09%-16.47%-38.78%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Allergan plc stock logo
AGN
Allergan
N/AN/AN/AN/AN/AN/AN/AN/A
CVS Health Co. stock logo
CVS
CVS Health
4.9144 of 5 stars
2.55.03.33.93.43.33.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.7803 of 5 stars
3.35.04.23.93.32.50.6
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
4.2306 of 5 stars
3.43.02.50.02.60.04.4
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
3.0455 of 5 stars
3.45.00.80.02.90.80.6
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
2.8348 of 5 stars
0.94.02.52.32.81.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allergan plc stock logo
AGN
Allergan
0.00
N/AN/AN/A
CVS Health Co. stock logo
CVS
CVS Health
2.91
Moderate Buy$71.944.89% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.61
Moderate Buy$171.7811.58% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.80
Moderate Buy$145.25131.00% Upside
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
2.86
Moderate Buy$23.4374.58% Upside
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
1.83
Reduce$10.59-1.94% Downside

Current Analyst Ratings Breakdown

Latest TEVA, JNJ, CVS, WBA, AGN, and NVO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
4/16/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$164.00 ➝ $169.00
4/15/2025
CVS Health Co. stock logo
CVS
CVS Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
4/15/2025
CVS Health Co. stock logo
CVS
CVS Health
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$51.00 ➝ $71.00
4/14/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$165.00 ➝ $162.00
4/11/2025
CVS Health Co. stock logo
CVS
CVS Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$76.00 ➝ $82.00
4/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$171.00 ➝ $159.00
4/9/2025
CVS Health Co. stock logo
CVS
CVS Health
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$70.00 ➝ $76.00
4/9/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$163.00 ➝ $164.00
4/9/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$157.00 ➝ $172.00
4/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
(Data available from 4/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allergan plc stock logo
AGN
Allergan
$16.09B3.95$36.70 per share5.26$177.28 per share1.09
CVS Health Co. stock logo
CVS
CVS Health
$372.81B0.23$9.58 per share7.16$60.06 per share1.14
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.18$12.65 per share12.17$29.69 per share5.19
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$290.40B0.97$2.92 per share21.57$4.64 per share13.55
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
$16.54B0.92$2.66 per share5.05$4.75 per share2.83
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$151.95B0.06$5.90 per share1.83$13.91 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allergan plc stock logo
AGN
Allergan
-$5.27B$17.64N/A10.651.63-15.44%8.46%5.31%N/A
CVS Health Co. stock logo
CVS
CVS Health
$4.61B$3.6618.7410.130.981.24%9.11%2.71%5/1/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6523.1513.912.5618.20%34.24%13.63%N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$14.64B$3.2919.1113.490.9034.81%84.68%26.29%5/7/2025 (Estimated)
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
-$1.64B-$1.45N/A5.101.44-9.91%42.46%6.65%5/7/2025 (Estimated)
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
-$8.64B-$6.69N/A7.401.31-5.87%17.61%2.89%6/26/2025 (Estimated)

Latest TEVA, JNJ, CVS, WBA, AGN, and NVO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.92N/AN/AN/A$79.17 billionN/A
5/7/2025Q1 2025
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
$0.47N/AN/AN/A$3.99 billionN/A
5/1/2025Q1 2025
CVS Health Co. stock logo
CVS
CVS Health
$1.62N/AN/AN/A$93.07 billionN/A
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
4/8/2025Q2 2025
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$0.53$0.63+$0.10-$3.30$37.90 billion$38.59 billion
2/12/2025Q4 2024
CVS Health Co. stock logo
CVS
CVS Health
$0.89$1.19+$0.30$1.30$96.90 billionN/A
2/5/2025Q4 2024
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.88$0.91+$0.03$0.91N/AN/A
1/29/2025Q4 2024
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
$0.69$0.70+$0.01-$0.19$4.10 billionN/A
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Allergan plc stock logo
AGN
Allergan
$2.961.53%N/A16.78%N/A
CVS Health Co. stock logo
CVS
CVS Health
$2.663.88%+9.97%72.68%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.22%+5.43%74.59%63 Years
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$1.632.59%+25.26%49.54%N/A
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
$1.017.53%N/AN/A N/A
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
$1.009.26%-19.12%N/A N/A

Latest TEVA, JNJ, CVS, WBA, AGN, and NVO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
3/20/2025
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66503.89%4/22/20254/22/20255/1/2025
2/5/2025
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
semi-annual$0.78741.2%3/31/20253/31/20254/8/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allergan plc stock logo
AGN
Allergan
0.31
1.01
0.84
CVS Health Co. stock logo
CVS
CVS Health
0.80
0.81
0.60
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.62
0.74
0.55
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
2.97
0.98
0.75
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
0.68
0.64
0.30
CompanyEmployeesShares OutstandingFree FloatOptionable
Allergan plc stock logo
AGN
Allergan
17,400329.00 millionN/AOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.26 billion1.26 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
54,4004.49 billion4.48 billionOptionable
Teva Pharmaceutical Industries Limited stock logo
TEVA
Teva Pharmaceutical Industries
36,8001.13 billion1.13 billionOptionable
Walgreens Boots Alliance, Inc. stock logo
WBA
Walgreens Boots Alliance
325,000864.74 million712.93 millionOptionable

Recent News About These Companies

Walgreens Boots Alliance: Last Change To Buy
Walgreens Boots Alliance: Last Change To Buy
Walgreens Boots Alliance: Last Chance To Buy

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allergan stock logo

Allergan NYSE:AGN

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. The company operates in three segments: US Specialized Therapeutics, US General Medicine, and International. It offers a portfolio of products in various therapeutic areas, including medical aesthetics and dermatology, eye care, neuroscience, urology, gastrointestinal, women's health, and anti-infective therapeutic products. The company also offers breast implants and tissue expanders; and RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis. In addition, it develops medical and cosmetic treatments; therapies for non-alcoholic steatohepatitis and other liver diseases; inhibitor for the treatment of psoriasis and other autoimmune disorders; atopic dermatitis drug candidate; peri-ocular rings for extended drug delivery and reducing elevated intraocular pressure in glaucoma patients; and treatments for neurodegenerative disorders, including Alzheimer's disease. Further, the company develops RST-001, a novel gene therapy for the treatment of retinitis pigmentosa; small molecule therapeutics for inflammatory and fibrotic diseases; topical medicines for fat reduction; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; and strategic alliance and option agreement with Editas Medicine, Inc. Allergan plc also has licensing agreements with Assembly Biosciences, Inc.; MedImmune; and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.

CVS Health stock logo

CVS Health NYSE:CVS

$68.59 -0.33 (-0.48%)
As of 04/16/2025 03:58 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$153.95 +0.33 (+0.21%)
As of 04/16/2025 03:59 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$62.88 -1.61 (-2.50%)
As of 04/16/2025 03:58 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teva Pharmaceutical Industries stock logo

Teva Pharmaceutical Industries NYSE:TEVA

$13.42 -0.18 (-1.32%)
As of 04/16/2025 03:58 PM Eastern

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; GRANIX; TRISENOX; LONQUEX; and TEVAGRASTIM/RATIOGRASTIM. In addition, it provides COPAXONE for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of neurodegenerative and movement disorders associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and long-acting beta-agonist bronchodilator; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv, Israel.

Walgreens Boots Alliance stock logo

Walgreens Boots Alliance NASDAQ:WBA

$10.80 -0.05 (-0.46%)
As of 04/16/2025 04:00 PM Eastern

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.